本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Acurx Pharmaceuticals, LLC*

0.3470
-0.0004-0.13%
盘前0.36660.0196+5.65%08:40 EDT
成交量:17.18万
成交额:6.00万
市值:814.81万
市盈率:-0.51
高:0.3550
开:0.3468
低:0.3412
收:0.3475
数据加载中...
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/02

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/29

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/10/02

重要事件披露

Form 8-K - Current report
2023/08/14

重要事件披露

Form 8-K - Current report
2023/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/06

SEC问询函

Form CORRESP - Correspondence
2023/06/30

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/06/21

重要事件披露

Form 8-K - Current report
2023/05/17

重要事件披露

Form 8-K - Current report